Sarah Cannon Research Institute
Angel Sherrill is a seasoned Clinical Project Lead at Sarah Cannon Research Institute, managing relationships and operations for multi-site clinical trials while facilitating collaboration across various teams to ensure high standards and timely deliverables. Previously, in the role of Clinical Trial Manager, Angel coordinated multiple phase II-III clinical trials, overseeing compliance with regulatory guidelines and optimizing study logistics. Prior experience includes serving as a Research Coordinator at Vanderbilt University Medical Center, where Angel managed the operations of a significant research study and facilitated participant recruitment. Academic credentials include a Master of Public Health from Tennessee State University and a Bachelor of Arts in Psychology from Fisk University.
This person is not in the org chart
This person is not in any teams
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.